JENNIFER ROSBOROUGH: Open Payments
NPI 1922100130 · DELRAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 54 payments from 12 companies in 2025. Trend: 2023 $1,644 · 2024 $671 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $210 |
| Novartis Pharmaceuticals Corporation | 13 | $181 |
| LEO Pharma Inc. | 5 | $77 |
| Janssen Biotech, Inc. | 4 | $69 |
| Incyte Corporation | 3 | $46 |
| Lilly USA, LLC | 3 | $45 |
| UCB, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
| Organon LLC | 2 | $19 |
Products named: COSENTYX, SKYRIZI, RINVOQ, TREMFYA, ADBRY, OPZELURA, TALTZ, Bimzelx.
Industry payments across NJ — which companies pay providers there.
